Actively Recruiting

Phase Not Applicable
Age: 40Years - 85Years
All Genders
Healthy Volunteers
ID05771844

Home Sleep Therapy System for Mild Cognitive Impairment

Led by Brain Electrophysiology Laboratory Company · Updated on 2025-02-17

60

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

B

Brain Electrophysiology Laboratory Company

Lead Sponsor

N

National Institute on Aging (NIA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the use of non-invasive transcranial electrical stimulation (TES) during deep slow-wave sleep in older adults with mild cognitive impairment (MCI). The study seeks to understand if TES delivered by a home-use sleep therapy device called SleepWISP can enhance deep sleep and improve memory performance. Additionally, the study will explore biomarkers related to Alzheimer's disease, such as beta-amyloid levels, to better understand potential links between sleep enhancement and disease markers. Participants will use the SleepWISP device, which includes a 16-channel EEG headband and electrical stimulation capabilities. The device measures brain activity during sleep and delivers low-level electrical current during slow-wave sleep to potentially increase its duration. The study has two phases: Phase I involves up to nine sleep sessions with baseline, TES, and sham conditions to test short-term effects, while Phase II is a six-week repeated-measures trial comparing TES and sham treatments in participants with and without MCI. Participants will also wear actigraphy watches to measure movement and sleep parameters. During the study, participants will complete memory tests before and after sleep sessions to assess memory retention. Blood samples or nasal swabs will be collected multiple times to measure Alzheimer's-related biomarkers. The study will monitor device usability daily and measure the duration and percentage of deep sleep during nights of participation. Participants will be observed for up to six weeks, with various assessments including depression inventories and memory performance tests to evaluate cognitive changes and safety.

CONDITIONS

Brief Title

Home Sleep Therapy for Older Adults With MCI

Who Can Participate

Age: 40Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • For participants with amnestic mild cognitive impairment (MCI), age must be between 55 and 85 years old
  • For healthy volunteers without MCI, age must be between 40 and 80 years old
Not Eligible

You will not qualify if you...

  • History of seizures or epilepsy
  • History of moderate or severe brain injury or trauma, including neurosurgery
  • Presence of significant neurological diseases such as Parkinson's disease
  • History of Electroconvulsive Therapy (ECT)
  • Severe insomnia
  • Untreated sleep apnea
  • Severe anxiety or depression
  • Use of medications that may affect EEG results
  • History of stroke
  • Sensitivity or allergy to lidocaine or silver
  • Active suicidal thoughts
  • Presence of metal in the head, implants, or medication infusion devices
  • Pregnancy
  • Adverse reactions to transcranial magnetic stimulation (TMS)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Phase I: Acute Sleep Sessions

Duration - Approximately 2 weeks

Participants use the Sleep WISP device at home for up to nine sleep sessions including baseline, active or sham transcranial electrical stimulation (TES) nights, and nights of passive EEG recording to evaluate short-term enhancement of slow-wave sleep (SWS).

3 sleep sessions over 10 days at home

Phase II: Repeated Sleep Therapy

Duration - 6 weeks

Participants wear the Sleep WISP device nightly for two weeks receiving either sham or active TES, followed by a 2-week washout without device use, then another two weeks receiving the opposite condition to assess cumulative effects on slow-wave sleep and memory.

Nightly device use for 4 weeks total with 2 weeks washout; blood or nasal swab samples collected 4 times

Trial Site Locations

Total: 2 locations

1

Wake Forest University

Winston-Salem, North Carolina, United States, 27109

Not Yet Recruiting

2

Brain Electrophysiology Laboratory Company

Eugene, Oregon, United States, 97405

Actively Recruiting

Loading map...

Research Team

D

Don M Tucker, PhD

P

Phan Luu, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Phase I Study to Assess the Safety, Tolerability and Preli...

Alzheimer's Disease

Actively Recruiting

2 locations

Quantitative Estimation of Preoperative Blood Volume Using M...

Blood Volume Analysis

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here